Pre-Market Analysis on MGIC Investment, Ultra Petroleum, Opko Health, and Accuray

  Pre-Market Analysis on MGIC Investment, Ultra Petroleum, Opko Health, and

PR Newswire

LONDON, March 15, 2013

LONDON, March 15, 2013 /PRNewswire/ --

It was a perfect 10 for the Dow Jones on Thursday as the benchmark index
finished higher for a tenth successive trading session. Once again, market
sentiment was lifted by better-than-expected economic data. A report from the
Labor Department showed that initial jobless claims fell unexpectedly for the
week ended March 9th. With stocks continuing to rally, it is not just
investors who are pouring money into equity markets but also company insiders.
Several companies, including MGIC Investment Corp. (NYSE: MTG), Ultra
Petroleum Corp. (NYSE: UPL), Opko Health Inc. (NYSE: OPK), and Accuray
Incorporated (NASDAQ: ARAY) have seen insider buying recently. StockCall has
posted free technical research on MTG, UPL, OPK, and ARAY which can be
downloaded upon sign up at

Mortgage insurer MGIC Investment Corp. has seen significant insider buying
this month. The company reported six major insider buys earlier this month,
including from its CFO and CEO. J. Michael Lauer, the company's CFO and
Executive Vice President, bought a total of 100,000 shares earlier this month
in two separate transactions. Curt Culver, the company's Chairman and CEO,
bought 50,000 shares on March 7^th. MGIC Investment Corp. shares ended lower
on Thursday. The stock finished 1.20% lower at $4.95 on volume of 17.78
million. The company's shares currently have a beta of 3.38. Sign up and read
the complimentary report on MTG at

Marshall Smith, CFO and Senior Vice President at Ultra Petroleum Corp.,
recently bought 1,000 shares of the company's common stock. Smith bought the
shares at $19.01 per share. Ultra Petroleum Corp. shares have had an excellent
run over the last three trading sessions, gaining more than 10%. On Thursday,
the stock rose 6.14% to finish at $20.75 on above average volume of 7.18
million. The Independent Oil & Gas company's shares have outperformed the
broad market in 2013, gaining more than 14%. The stock currently has a beta of
0.85. The free report on UPL can be downloaded by signing up now at

Opko Health Inc. Chairman and CEO Phillip Frost has bought shares of the
company's stock in several transactions since the start of this month. On
March 12, Frost bought 37,100 shares of Opko Health Inc. common stock. A day
before, he bought 23,500 shares of Opko Health Inc. common stock. The
company's shares ended marginally higher in Thursday's session. The stock
closed 0.40% higher at $7.54 on volume of 1.74 million. The stock is currently
trading close to its 52-week high of $7.59. Year-to-date, Opko Health's shares
have gained more than 56%. Free report on OPK can be accessed by registering

Dennis Winger, Independent Director at Accuray Incorporated, recently bought
20,000 shares of the company's common stock at $4.30 per share. Winger made a
total investment of $85,938. On Thursday, Accuray's shares rose sharply. The
stock ended the day 3.53% higher at $4.69 on volume of 1.62 million after
hitting an intra-day high of $4.72. Despite the sharp rise in yesterday's
session, the company's shares have fallen more than 27% this year, even as the
broad market has rallied. The stock currently has a beta of 1.06. Register
with StockCall and download the research on ARAY for free at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at 


Contact: William T. Knight, Email:, Contact Number:
+1-646-396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.